Treatment progress of elderly patients with acute promyelocytic leukemia / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 60-64, 2019.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-732686
Biblioteca responsável:
WPRO
ABSTRACT
Acute promyelocytic leukemia (APL) is a special subtype of acute myeloid leukemia characterized by an increase of abnormal promyelocytic cells, failure of bone marrow hematopoietic function accompanied by the chromosome translocation t (15;17). APL has become one of the best paradigms of successful molecule targeted therapy with the development of treatments; however, the overall survival (OS) of elderly APL patients was not optimistic. The discovery of all-trans retinoic acid, arsenic and new drugs has provided new therapeutic choices for elderly patients with APL. This article reviews the treatment progress of elderly patients with APL.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of Leukemia & Lymphoma
Ano de publicação:
2019
Tipo de documento:
Artigo